Optomed Oyj : and Toku Inc. enter a partnership to commercialize AI for Cardiovascular Disease Risk
Optomed and Toku Inc. enter a partnership to commercialize AI for Cardiovascular Disease Risk Optomed Plc Press Release 30 May 2024 at 9.00, Helsinki Optomed...
Source: marketscreener.com